Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Molecular Cell
|
September 25, 2007
RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein
David Matallanas, David Romano, Karen Yee, et al.
Plos Computational Biology
|
October 8, 2016
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
Goar Sánchez-Sanz, Bartłomiej Tywoniuk, David Matallanas, et al.
Human Brain Mapping
|
April 17, 2014
Topological methods reveal high and low functioning neuro-phenotypes within fragile X syndrome
David Romano, Monica Nicolau, Eve-Marie Quintin, et al.
Oncotarget
|
September 15, 2017
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma <i>in vitro</i>
Thomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neurosurgery
|
December 17, 2016
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
Thomas Graillon, David Romano, Céline Defilles, et al.
Plos One
|
June 13, 2015
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation
Malgorzata Milewska, David Romano, Ana Herrero, et al.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Environmental Science and Pollution Research International
|
March 14, 2014
Impacts from control operations on a recreationally hunted feral swine population at a large military installation in Florida
Richard Engeman, Troy Hershberger, Steve Orzell, et al.
Cellular Signalling
|
June 28, 2016
Autophosphorylation on S614 inhibits the activity and the transforming potential of BRAF
Layal Dernayka, Nora Rauch, Mohamed-Ali Jarboui, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Molecular Cell
|
September 25, 2007
RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein
David Matallanas, David Romano, Karen Yee, et al.
Plos Computational Biology
|
October 8, 2016
SARAH Domain-Mediated MST2-RASSF Dimeric Interactions
Goar Sánchez-Sanz, Bartłomiej Tywoniuk, David Matallanas, et al.
Human Brain Mapping
|
April 17, 2014
Topological methods reveal high and low functioning neuro-phenotypes within fragile X syndrome
David Romano, Monica Nicolau, Eve-Marie Quintin, et al.
Oncotarget
|
September 15, 2017
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma <i>in vitro</i>
Thomas Graillon, David Romano, Céline Defilles, et al.
Journal of Neurosurgery
|
December 17, 2016
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review
Thomas Graillon, David Romano, Céline Defilles, et al.
Plos One
|
June 13, 2015
Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation
Malgorzata Milewska, David Romano, Ana Herrero, et al.
Molecular Cell
|
December 27, 2011
Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras
David Matallanas, David Romano, Fahd Al-Mulla, et al.
Environmental Science and Pollution Research International
|
March 14, 2014
Impacts from control operations on a recreationally hunted feral swine population at a large military installation in Florida
Richard Engeman, Troy Hershberger, Steve Orzell, et al.
Cellular Signalling
|
June 28, 2016
Autophosphorylation on S614 inhibits the activity and the transforming potential of BRAF
Layal Dernayka, Nora Rauch, Mohamed-Ali Jarboui, et al.
Oncotarget
|
April 29, 2017
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
Amira Mohamed, David Romano, Alexandru Saveanu, et al.
Page
of 4